The relative bioavailability of two formulations containing 10 mg Dapagliflozin assessed under fasting conditions in a randomized crossover study in healthy Caucasian subjects
Authors
Monica Oroian
Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy „Iuliu Haţieganu”, Cluj-Napoca, Romania
Clinical Pharmacology and Pharmacokinetics Department, Cluj-Napoca, Romania
Diana Ioana Pop
Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy „Iuliu Haţieganu”, Cluj-Napoca, Romania
Clinical Pharmacology and Pharmacokinetics Department, Cluj-Napoca, Romania
Ana-Maria Gheldiu
Department of Pharmaceutical Botany, Faculty of Pharmacy, University of Medicine and Pharmacy „Iuliu Haţieganu”, Cluj-Napoca, Romania
Sandeep Bhardwaj
Clinical Pharmacology and Pharmacokinetics Department, Cluj-Napoca, Romania
Adriana Marcovici
Clinical Pharmacology and Pharmacokinetics Department, Cluj-Napoca, Romania
Arshad Khuroo
Clinical Pharmacology and Pharmacokinetics Department, Gurugram, India
Laurian Vlase
Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy „Iuliu Haţieganu”, Cluj-Napoca, Romania
Language: English
Page range: 30 - 34
Submitted on: Aug 1, 2019
Accepted on: Jan 29, 2020
Published on: Mar 31, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 Monica Oroian, Diana Ioana Pop, Ana-Maria Gheldiu, Sandeep Bhardwaj, Adriana Marcovici, Arshad Khuroo, Laurian Vlase, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.